Interim report:” Strategic progress and well positioned for the second half of the year”

The important signal here is not the revenue miss; it is that the company preserved EBITA on lower volume by sharply expanding gross margin. That usually means either mix/pricing improved or low-margin orders were deliberately deprioritized, which is healthier than chasing sales at the expense of profitability. In the near term, the market should treat this as a quality-of-earnings upgrade, but not yet as proof of demand inflection.

Second-order, this is constructive for peers that can defend price and manage assortment, and negative for lower-quality competitors still leaning on volume to mask weak unit economics. If Client Brand order timing is the main issue, the softness may reverse in 1 quarter; if it is share loss, the revenue trend is a 6-18 month problem and the current margin strength will eventually prove temporary. The key is whether cash flow keeps tracking EBITA, because that would confirm the margin gain is real rather than working-capital noise.

The contrarian risk is that investors may overreact to the sales decline and miss that the earnings power of the business may actually be stabilizing. Conversely, the bullish read is fragile if the next print shows the same ordering pattern without a rebound in organic growth; then this becomes a margin peak story with limited multiple support. Falsifiers: a second consecutive organic decline, gross margin retracement back toward the mid-50s, or deteriorating operating cash flow despite stable EBITA.